Cases | Percentages | |
---|---|---|
Gender | ||
Male | 72 | 91 |
Female | 7 | 9 |
Cancer site | ||
Oral cavity and Oropharynx | 29 | 36.7 |
Larynx and Hypopharynx | 26 | 32.9 |
Nasopharynx and Unknown origin/Multiple | 24 | 30.4 |
Stage | ||
III | 20 | 25.3 |
IVA | 42 | 53.2 |
IVB | 17 | 21.5 |
Histology | ||
Epidermoid | 67 | 84.8 |
Others | 12 | 15.2 |
RT schedule | ||
Conventional | 35 | 44.3 |
Hyperfractionated | 44 | 55.7 |
Concomitant treatments | ||
CMT | 42 | 53.2 |
Surgery | 20 | 25.3 |
Amifostine | 23 | 29.1 |